Cna Financial Corp Beyond Spring Inc. Transaction History

Cna Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.02 - $16.84 $79,451 - $332,825	-19,764 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$9.26 - $31.31 $107,508 - $363,509	-11,610 Reduced 37.01%	19,764 $311,000
Q2 2021 Aug 12, 2021	BUY	$9.37 - $12.12 $27,828 - $35,996	2,970 Added 10.46%	31,374 $328,000
Q1 2021 May 14, 2021	BUY	$10.61 - $15.77 $43,819 - $65,130	4,130 Added 17.01%	28,404 $314,000
Q4 2020 Feb 12, 2021	BUY	$10.21 - $17.31 $247,837 - $420,182	24,274 New	24,274 $296,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.